..

ctor treatment for alloimmun neonatal neutropenia Arch. Dis. Chied, 1996,75,57-58.

364. Rodwell R, Shin R. et al. Intavenous gamma-globulin in treatment of isoimmune neonatal neutropeina J. Pediatr, 1995, 127,508-509.

365. RosenfeldR.L, BarnesR. etal. Dysregulation of cytochrome P450-17a as a cause of polycystic ovarian syndrom Fertil. Steril, 1990, 53, 785-791.

366. Rothchild J. Role of progesterone in initiating and maintaining pregnancy. In Progesterone and Progestins Raven Press, New-York, 1983, 219-229.

367. Antiphospholipid fetal loss Lab. Med., 1992,

12, 1,41-59.

368. Sanson B.J., Lensing A.M. et al. Safety of low-molecular weight heparin in pregnancy: a systemic review Thromb. Haemost., 1999, 81, 668672.

369. Scott J.R., Rote N., Branch D. Immunologic aspects of recurrent abortion and fetal death Odstet. Gynec., 1987, 70, 645.

370. Scott R.T., SynderR.R. etal. The effect of interobservervariation in dating endometrial history on the diagnosis of luteal phase defectsFertil. Steril., 1988, 50, 888.

371. Seibel M.M. Toward uderstanding the pathophysiology and treatment of polycystic ovary desease Semin.-Reprod. Endocrin., 1984, 2, 297.

372. Shehata H., Nelson-Piercy C., Khamashta M. Management of pregnancy in antiphospholipid syndrom Rheumatic Disease Clinics of North America, 2001, 27, 3.

373. SheltonA.J., HarherJ.M.etal. Association between familial autoimmune disease and recurrent spontaneous abortions Am. J. Reprod. Immunol., 1994, 32, 8287.

374. Shi Q.J. et al. Novel role of human chorinic gonadotropine in differentiation of human cytotrophoblastasEndocrinology, 1993,132, 1387.

375. Shingu M. Laboratory diagnosis of viral myocarditis Iph Cirl. J., 1989,53, 1, 8793.

376. Shiokawa S., Sakai K. et al. Function of the small guanosine triphospate binding protein RhoA in the process of implantation Jorn. Clinical Endocrin and Metabolism, 2000, 85, 12,4742.

377. Shirodkar V.N. Habitual abortion in the second trimester In. Contributions to Obstetrics and Gynecology ShirodkarV. N. (ed), Edinburgh, Livingstone.

378. Siiter P.K., Febres F. et al. Progesterone and maintenance of pregnancy: Is progesterone nature's immunosuppressantAm. NYAcad.Sci., 1977, 286, 384.

379. Silman R.E., Chard T. etal. Human pituitary peptides and parturition Nature, 1976, 260,716.

380. Simon Marinex L. et al. Mullerian defects in women with normal reproductive outcome

381. Spatling L., Spatling C. Magnesium supplementation in pregnancy. A double-blind study Br. J. Obstet. Gynecol., 1988, 95,120125.

382. SpectorW.C. Hand book of biological data. PhiladephiaW.B. Saunders, 1956,353.

383. SpeiserP.W., Dupont B. etal. High frequency of non classical steroid 21 -hydroxylase deficiency Hum. 1985, 37, 650.

384. Speiser P.W., New M., White P.C. Molecular genetic analysis of non classic steroid 21-hydroxylase deficiency associated with HLA-B 14, DRI N.Engl.J. Med., 1988, 319, 19-23.

385. Spellacy W.N. Human placental lactogen in high-risk pregnancy Clin. Obstet. Gynecol., 1973,16, 298312.

386. Speroff L., Glass R.H. et al. Clinical gynecologic endocrinology and infertility 5 ed Baltimore Williams a.Wilkins, 1994.

387. Spinnato J.A., Clark A.L. et al. Intravenous immunoglobulin therapy for the antiphospholipid syndrome in pregnancy Am.J.Obstet.Gynecol., 1995, 172, 690 694.

388. Sokol R.Z., Mellure R.D. et al. Gonadotropin therapy failure secondary to human gonadotropin induced antibodies J. of Clin. Endocr. And Metab.,1980, 52,5, 929 933.

389. Stagno S. et al. Herpes virus intections of pregnancy Part I, Cytomegalovirus and

virus infections N. 1985,

390. Stampe-Sorensen S. Estimated prevalence of mullerian anomalies Acta Obstet.

Gynecol. Scand., 1988, 67, 441.

391. Strassmann .. Operations for double uterus and endometrial atresia Clin.Obstet.Gynecol, 1961, 4, 240-242.

392. Suciu-Foca N, Reed E. et al. Antiidiotypic antibodies to anti-HLA receptors induced by pregnancy Proc. Natl. Acad. Sci. USA, 1983,80,830.

393. Stagnara-Green A. et al. Detection of at risk pregnancy by meensof highly sensitive assays for thyroid autoantibodies JAMA, 1990, 264, 1422-1425.

394. Szendi B. Operative treatment of insufficiency of the cervical os in pregnancy -Wien.Klin.Wsch.,1961, Bd73, 618-620.

395. Taemadge K, Vamvakopoulas N.. Fiddes J. Evolution of the genes for the beta-subunits of human gonodotropin and luteinizing hormone Nature, 1984, 307, 37.

396. Takakuwa K, Kanazawa K. et al. Production of blocking antibodies by vaccination with husband's lympocytes in unexplained recurrent aborters; the role in succesful pregnancy-Am.J.Reprod. Immunol. Microbiol, 1986, 10, 1.

397. Talwar G.P, Singh O, Pal R. et al. A vaccine that prevents pregnancy in women J.Biochem (Tokyo), 1994, 115(3), 596-601.

398. Tayler C, Faulk M.P. Preventing recurrent abortion with l

150
< > 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151

" " (9.33Mb)


[]  []  [ ]  [ ]


 Rambler's Top100

Copyright 2009
(23.02.2019)